Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold

NCT03794804 is registered in ClinicalTrials.gov with Enzymatica AB as lead sponsor.

NCT NCT03794804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03794804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold
Lead sponsor
Enzymatica AB
Phase
Not applicable
Overall status
Completed
Start date
January 28, 2019
Completion date
June 26, 2019
Enrollment
701 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

common cold